Trial · NCT02147158
Adverse events324
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 324
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Placebo (Treatment Course 1) | 5 | 116 | |
| other | Nausea | Gastrointestinal disorders | UPA 5 mg (Treatment Course 1) | 13 | 161 | |
| other | Nausea | Gastrointestinal disorders | UPA 10 mg (Treatment Course 1) | 4 | 155 | |
| other | Nausea | Gastrointestinal disorders | UPA 5 mg:Placebo (Treatment Course 2) | 0 | 40 | |
| other | Nausea | Gastrointestinal disorders | UPA 10 mg:Placebo (Treatment Course 2) | 2 | 33 | |
| other | Nausea | Gastrointestinal disorders | UPA 5 mg:UPA 5 mg (Treatment Course 2) | 3 | 84 | |
| other | Nausea | Gastrointestinal disorders | UPA 10 mg:UPA 10 mg (Treatment Course 2) | 0 | 82 | |
| other | Nausea | Gastrointestinal disorders | Placebo:UPA 5 mg (Treatment Course 2) | 0 | 42 | |
| other | Nausea | Gastrointestinal disorders | Placebo:UPA 10 mg (Treatment Course 2) | 3 | 44 | |
| other | Fatigue | General disorders | Placebo (Treatment Course 1) | 5 | 116 | |
| other | Fatigue | General disorders | UPA 5 mg (Treatment Course 1) | 6 | 161 | |
| other | Fatigue | General disorders | UPA 10 mg (Treatment Course 1) | 8 | 155 | |
| other | Fatigue | General disorders | UPA 5 mg:Placebo (Treatment Course 2) | 0 | 40 | |
| other | Fatigue | General disorders | UPA 10 mg:Placebo (Treatment Course 2) | 0 | 33 | |
| other | Fatigue | General disorders | UPA 5 mg:UPA 5 mg (Treatment Course 2) | 0 | 84 | |
| other | Fatigue | General disorders | UPA 10 mg:UPA 10 mg (Treatment Course 2) | 0 | 82 | |
| other | Fatigue | General disorders | Placebo:UPA 5 mg (Treatment Course 2) | 0 | 42 | |
| other | Fatigue | General disorders | Placebo:UPA 10 mg (Treatment Course 2) | 0 | 44 | |
| other | Nasopharyngitis | Infections and infestations | Placebo (Treatment Course 1) | 2 | 116 | |
| other | Nasopharyngitis | Infections and infestations | UPA 5 mg (Treatment Course 1) | 8 | 161 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02147158/events